Vivo Bio Tech Limited (BOM:511509)
14.90
+0.83 (5.90%)
At close: Oct 7, 2026
Vivo Bio Tech Revenue
Vivo Bio Tech had revenue of 142.80M INR in the quarter ending June 30, 2026, with 14.13% growth. This brings the company's revenue in the last twelve months to 551.03M, up 12.34% year-over-year. In the fiscal year ending March 31, 2026, Vivo Bio Tech had annual revenue of 533.35M with 14.27% growth. That makes Vivo Bio Tech the world's 39,499th largest company by revenue and 3,675th in India.
Revenue (ttm)
551.03M
Revenue Growth
+12.34%
P/S Ratio
0.60
Revenue / Employee
2.23M
Employees
247
Market Cap
330.64M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 533.35M | 66.62M | 14.27% |
| Mar 31, 2025 | 466.73M | 12.21M | 2.69% |
| Mar 31, 2024 | 454.51M | -67.79M | -12.98% |
| Mar 31, 2023 | 522.30M | 8.39M | 1.63% |
| Mar 31, 2022 | 513.91M | -3.84M | -0.74% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Rishi Techtex | 1.64B |
| Poona Dal and Oil Industries | 1.41B |
| Akshar Spintex | 1.21B |
| Swasti Vinayaka Synthetics | 318.30M |
| Homre | 272.09M |
| Umiya Tubes | 263.45M |
| Nettlinx | 199.45M |
| Medi-Caps | 125.48M |